Our top pick for
The Bancorp Inc is a banks-regional business based in the US. The Bancorp shares (TBBK) are listed on the NASDAQ and all prices are listed in US Dollars. The Bancorp employs 635 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$29.82|
|52-week range||$8.84 - $30.76|
|50-day moving average||$24.89|
|200-day moving average||$23.66|
|Wall St. target price||$30.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.74|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-2.49%|
|1 month (2021-09-16)||28.81%|
|3 months (2021-07-16)||37.42%|
|6 months (2021-04-16)||30.16%|
|1 year (2020-10-16)||215.22%|
|2 years (2019-10-16)||198.80%|
|3 years (2018-10-16)||213.56%|
|5 years (2016-10-14)||326.00%|
Valuing The Bancorp stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Bancorp's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Bancorp's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, The Bancorp shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
The Bancorp's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.46. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Bancorp's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$305.4 million|
|Operating margin TTM||47.66%|
|Gross profit TTM||$273.1 million|
|Return on assets TTM||1.6%|
|Return on equity TTM||17.77%|
|Market capitalisation||$1.7 billion|
TTM: trailing 12 months
There are currently 1.7 million The Bancorp shares held short by investors – that's known as The Bancorp's "short interest". This figure is 3.6% down from 1.8 million last month.
There are a few different ways that this level of interest in shorting The Bancorp shares can be evaluated.
The Bancorp's "short interest ratio" (SIR) is the quantity of The Bancorp shares currently shorted divided by the average quantity of The Bancorp shares traded daily (recently around 277268.64951768). The Bancorp's SIR currently stands at 6.22. In other words for every 100,000 The Bancorp shares traded daily on the market, roughly 6220 shares are currently held short.
However The Bancorp's short interest can also be evaluated against the total number of The Bancorp shares, or, against the total number of tradable The Bancorp shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Bancorp's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 The Bancorp shares in existence, roughly 30 shares are currently held short) or 0.0316% of the tradable shares (for every 100,000 tradable The Bancorp shares, roughly 32 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against The Bancorp.
Find out more about how you can short The Bancorp stock.
We're not expecting The Bancorp to pay a dividend over the next 12 months.
Over the last 12 months, The Bancorp's shares have ranged in value from as little as $8.84 up to $30.76. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while The Bancorp's is 1.4243. This would suggest that The Bancorp's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
The Bancorp, Inc. operates as the financial holding company for The Bancorp Bank that provides banking products and services in the United States. The company offers a range of deposit products and services, including checking, savings, money market, and commercial accounts. It also provides securities-backed lines of credit, insurance policy cash value-backed lines of credit, vehicle fleet and other equipment leasing, small business administration loans, and commercial mortgage-backed loans, as well as prepaid and debit cards. The company offers private label banking; credit and debit card payment processing for independent service organizations; institutional banking; and internet banking services. The Bancorp, Inc. was incorporated in 1999 and is headquartered in Wilmington, Delaware.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.